Discover 3,553 paid clinical trials in Glendale, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,553
A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer
for
Gastric Adenocarcinoma, Gastric Cancer,
Location: Santa Monica CA, Duarte CA, Irvine CA, Fort Worth TX,
Sponsor: Toray Industries, Inc
Sex: All
Age: 18+
Code: NCT06038578
Phase2, Recruiting
An Integrated Intervention Using a Pill Ingestible Sensor System
for
HIV/AIDS, Medication Adherence,
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18+
Code: NCT06480578
Phase2, Recruiting
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant
for
Hematologic Malignancies
Location: Los Angeles CA
Sponsor: Ronald Paquette
Sex: All
Age: 65+
Code: NCT05849207
Phase1, Recruiting
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
A Pilot Feasibility Trial of Thyroid Hormone Replacement in Dialysis Patients
for
Thyroid Disease, Kidney Diseases, Chronic
Location: Orange CA
Sponsor: University of California, Irvine
Sex: All
Age: 18 - 70+
Code: NCT03191188
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)
for
Severe Asthma
Location: Pasadena CA, Northridge CA, West Hills CA, Valencia CA,
Sponsor: Generate Biomedicines
Sex: All
Age: 12 - 70+
Code: NCT07276724
Phase3, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Los Angeles CA, Beverly Hills CA, Tarzana CA,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase2, Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)